NCT01397929View on ClinicalTrials.gov

An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

April 30, 2016

Conditions
Solid Organ Tumors
Interventions
DRUG

BAL101553

Intravenous administration

Trial Locations (3)

SM2 5PT

Royal Marsden Hospital, Sutton

WC1E 2PG

University College London NHS Foundation Trust, London

NE7 7DN

Sir Bobby Robson Cancer Trials Research Centre; Northern Centre for Cancer Care, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Basilea Pharmaceutica

INDUSTRY